Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib

J Thorac Oncol. 2012 Nov;7(11):e27-8. doi: 10.1097/JTO.0b013e3182653da2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / genetics
  • Adenocarcinoma / secondary*
  • Adult
  • Antineoplastic Agents / therapeutic use*
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology*
  • Male
  • Mutation / genetics
  • Neoplastic Cells, Circulating / pathology*
  • Positron-Emission Tomography*
  • Prognosis
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • EGFR protein, human
  • ErbB Receptors
  • Gefitinib